Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 104Colorectal Neoplasms 63Stomach Neoplasms 49Rectal Neoplasms 42Colonic Neoplasms 24Neoplasm Metastasis 21Nasopharyngeal Carcinoma 19Triple Negative Breast Neoplasms 18Pancreatic Neoplasms 14Parkinson Disease 4, Autosomal Dominant Lewy Body 12Neoplasms 12Gallbladder Neoplasms 7Cholangiocarcinoma 7Adenocarcinoma 6Esophageal Neoplasms 5Biliary Tract Neoplasms 5Adenocarcinoma Of Esophagus 5Esophageal Squamous Cell Carcinoma 4Neuroendocrine Tumors 3Gastrointestinal Neoplasms 3Digestive System Neoplasms 3Bile Duct Neoplasms 3Recurrence 2Pathologic Complete Response 2Liver Neoplasms 2Intestinal Neoplasms 2Hand-Foot Syndrome 2HER2-positive Advanced Breast Cancer 2HER2 Positive Metastatic Breast Cancer 2Drug-Related Side Effects and Adverse Reactions 2

Interventions

dehydroftorafur 1X-Rays 1Specimen Handling 1Secretin 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pancreatic Intraductal Neoplasms × Capecitabine × Clear all
NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
546 enrolled 29 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡